Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;7(1):e000724.
doi: 10.1136/bmjresp-2020-000724.

SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?'

Affiliations
Review

SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?'

Pierre Kory et al. BMJ Open Respir Res. 2020 Sep.

Abstract

Reviews of COVID-19 CT imaging along with postmortem lung biopsies and autopsies indicate that the majority of patients with COVID-19 pulmonary involvement have secondary organising pneumonia (OP) or its histological variant, acute fibrinous and organising pneumonia, both well-known complications of viral infections. Further, many publications on COVID-19 have debated the puzzling clinical characteristics of 'silent hypoxemia', 'happy hypoxemics' and 'atypical ARDS', all features consistent with OP. The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with OP given that corticosteroid therapy is the first-line treatment. Although RECOVERY along with other cohort studies report positive effects with corticosteroids on morbidity and mortality of COVID-19, treatment approaches could be made more effective given that secondary OP often requires prolonged duration and/or careful and monitored tapering of corticosteroid dose, with 'pulse' doses needed for the well-described fulminant subtype. Increasing recognition of this diagnosis will thus lead to more appropriate and effective treatment strategies in COVID-19, which may lead to a further reduction of need for ventilatory support and improved survival.

Keywords: imaging/CT MRI etc; pneumonia; rare lung diseases; viral infection.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Photomicrograph shows immature collagen plugs or Masson bodies (arrows) filling the airspaces. There is mild chronic interstitial inflammation. (H&E, medium power).
Figure 2
Figure 2
37-year-old woman with COVID-19 requiring FiO2 of 1.0 delivered via heated humidified high-flow nasal cannula for 8 days. On day 8, initiation of treatment with ‘pulse-dose’ methylprednisolone 1000 mg intravenously for 3 days was followed by an abrupt reduction in oxygen needs and eventual discharge on ambient air. (A) Contrast-enhanced thin-section CT image 6 days after onset of symptoms shows peripheral and peri-bronchial ground-glass opacity in both lungs typical of an organising pneumonia pattern of lung injury. (B) Unenhanced CT image 2 weeks after discharge shows marked clearing of ground-glass opacity with small foci of lung consolidation and minimal traction bronchiectasis (arrows) suggesting mild fibrosis.

References

    1. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 2020;202:356–60. 10.1164/rccm.202006-2157CP - DOI - PMC - PubMed
    1. Couzin-Frankel J. The mystery of the pandemic's 'happy hypoxia'. Science 2020;368:455–6. 10.1126/science.368.6490.455 - DOI - PubMed
    1. Gattinoni L, Chiumello D, Caironi P, et al. . COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46:1099–102. 10.1007/s00134-020-06033-2 - DOI - PMC - PubMed
    1. Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics 2013;33:1951–75. 10.1148/rg.337130057 - DOI - PubMed
    1. Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, et al. . Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest 2011;139:893–900. 10.1378/chest.10-0883 - DOI - PubMed

MeSH terms

LinkOut - more resources